BillionToOne (BLLN) News
NASDAQ: BLLNHealth CareMedical SpecialitiesUSD
89.92-0.28 (-0.31%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
BLLN news summary
We found 12 recent headlines mentioning BillionToOne (BLLN): 8 in the past week and 11 in the past 30 days, most often from GlobeNewswire, PR Newswire, Seeking Alpha. For price context, BLLN is down 0.31% at $89.92. The most recent story, "BLLN SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving BillionToOne", was published by PR Newswire on Nov 19, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest BillionToOne headlines
- BLLN SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving BillionToOneBillionToOne raised its 2026 revenue outlook on November 4. Fourteen days later, a short-seller report alleging improper billing practices sent BLLN shares down, and shareholders who lost money may…PR Newswire
- BillionToOne Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into BillionToOne (BLLN)Short-seller Fuzzy Panda Research alleged undisclosed regulatory scrutiny at BillionToOne. Two weeks earlier, the Company's quarterly report said the government inquiries it faces were not material…PR Newswire
- BillionToOne Responds to Inaccurate and Misleading Short Seller ReportMENLO PARK, Calif., Nov. 18, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (Nasdaq: BLLN), a molecular diagnostics company today responded to a report published on November 18, 2026 by Fuzzy Panda…GlobeNewswire
- BillionToOne falls after Fuzzy Panda Research short reportSeeking Alpha
- Why is BillionToOne stock sliding today?Investing.com
- BillionToOne shares slide in pre-market trading following short-seller reportInvesting.com
- BillionToOne to Participate in the Piper Sandler 38th Annual Healthcare ConferenceMENLO PARK, Calif., Nov. 18, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are…GlobeNewswire
- BillionToOne: 3 Key Takeaways for Long-Term InvestorsKey PointsBillionToOne raised 2026 revenue guidance to $460 million to $470 million.Nasdaq
- BillionToOne raises 2026 revenue outlook to $460M-$470M while launching Northstar Clear on December 15Seeking Alpha
- Baxter International (BAX) Q3 Earnings and Revenues Surpass EstimatesBaxter (BAX) delivered earnings and revenue surprises of +13.73% and +2.48%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?NasdaqBAX, BLLN
- BillionToOne to Participate in Two Upcoming Investor ConferencesMENLO PARK, Calif., Oct. 27, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are…GlobeNewswire
- BillionToOne to Report Third Quarter 2026 Financial Results on November 4, 2026MENLO PARK, Calif., Oct. 14, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are…GlobeNewswire